- Home
- VALU vs OLMA Comparison
VALU vs OLMA Comparison
Compare VALU & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALU
- OLMA
- Stock Information
- Founded
- VALU 1931
- OLMA 2006
- Country
- VALU United States
- OLMA United States
- Employees
- VALU N/A
- OLMA 88
- Industry
- VALU Investment Managers
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- VALU Finance
- OLMA Health Care
- Exchange
- VALU Nasdaq
- OLMA Nasdaq
- Market Cap
- VALU 491.0M
- OLMA 465.4M
- IPO Year
- VALU N/A
- OLMA 2020
- Fundamental
- Price
- VALU $53.37
- OLMA $5.92
- Analyst Decision
- VALU
- OLMA Strong Buy
- Analyst Count
- VALU 0
- OLMA 5
- Target Price
- VALU N/A
- OLMA $26.25
- AVG Volume (30 Days)
- VALU 10.3K
- OLMA 1.0M
- Earning Date
- VALU 12-13-2024
- OLMA 11-12-2024
- Dividend Yield
- VALU 2.22%
- OLMA N/A
- EPS Growth
- VALU 26.35
- OLMA N/A
- EPS
- VALU 2.36
- OLMA N/A
- Revenue
- VALU $35,859,000.00
- OLMA N/A
- Revenue This Year
- VALU N/A
- OLMA N/A
- Revenue Next Year
- VALU N/A
- OLMA N/A
- P/E Ratio
- VALU $22.72
- OLMA N/A
- Revenue Growth
- VALU N/A
- OLMA N/A
- 52 Week Low
- VALU $36.00
- OLMA $6.10
- 52 Week High
- VALU $57.68
- OLMA $16.78
- Technical
- Relative Strength Index (RSI)
- VALU 58.30
- OLMA 23.84
- Support Level
- VALU $51.74
- OLMA $6.25
- Resistance Level
- VALU $53.29
- OLMA $6.87
- Average True Range (ATR)
- VALU 1.29
- OLMA 0.82
- MACD
- VALU 0.11
- OLMA -0.34
- Stochastic Oscillator
- VALU 93.32
- OLMA 0.00
About VALU Value Line Inc.
Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and a trusted name in Investment Research. Its only operating segment being Publishing.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.